Michele Cottler‐Fox

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Michele Cottler‐Fox, J. O’Shaughnessy, S Doren et al. · Blood · 1995 · 478 citations

Medicine, Cell Biology, Hematology +14

Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

Bart Barlogie, Elias Anaissie, Frits van Rhee et al. · British Journal of Haematology · 2007 · 326 citations · Full text

Medicine, Hematology, Oncology +17

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

Dimitriοs Mavroudis, E.J. Read, Michele Cottler‐Fox et al. · Blood · 1996 · 243 citations · Full text

Medicine, Cell Biology, Hematology +17

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

Jumei Shi, Guido Tricot, Susann Szmania et al. · British Journal of Haematology · 2008 · 193 citations

Life Sciences, Hematology, Immunology +17